Clinical Trial Materials

Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News

AveXis Enters Mfg. Pact for Novel Genetic COVID-19 Vax

AAVCOVID, being developed by U.S. researchers in Massachusetts, leverages adeno-associated viral vector technology to produce immunity.

Contract Pharma Staff 05.28.20

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News

Advent Srl Manufactures 13,000 Doses of Novel Covid-19 Vax

The first 4,000 doses have been delivered for use in the Phase II/III clinical trial COV002 by the University of Oxford.

Contract Pharma Staff 05.28.20

Analytical Services | Breaking News | Clinical Trial Materials | Industry News

Almac Receives Grant to Support COVID-19 Studies

Almac Clinical Services to provide clinical trial services from protocol through to patient delivery, and Almac Sciences will provide analytical support.

Contract Pharma Staff 05.28.20

Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Drug Development | Process Development

Arranta Bio Expands Microbiome Capacity at CoE

Adds additional early-clinical GMP capacity for microbiome process development and early clinical supply at Gainesville, FL site.

Contract Pharma Staff 05.28.20

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News

Takara Bio, AGC Biologics Enter Plasmid DNA Mfg. Pact

AGC to manufacture plasmid DNA intermediate for COVID-19 vaccine candidate.

Contract Pharma Staff 05.21.20

Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News

Catalent Acquires Clinical Packaging Facility in Japan

Establishes a new clinical GMP manufacturing and distribution hub to support local and global clinical studies.

Contract Pharma Staff 05.21.20

Vibalogics to Manufacture Clinical Material for Janssen

CDMO to provide additional clinical trial material for COVID-19 vaccine candidate

Contract Pharma Staff 05.14.20

Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News

Sabin and ReiThera Enter Clinical Manufacturing Pact

BARDA provides the Sabin Vaccine Institute with additional $20mn for further development of Ebola Sudan and Marburg vaccines

Contract Pharma Staff 05.14.20

Breaking News | Clinical Trial Materials | Industry News | Logistics | Supply Chain

Marken Expands Direct To Patient Services

India allows home delivery of clinical trial medications during COVID-19 pandemic lock down.

Contract Pharma Staff 05.13.20

Yourway and Firma Ink Clinical Supply Deal

Collaborate to administer coordinated supply delivery for home-health clinical trial visits

Contract Pharma Staff 05.12.20

Catalent Provides Clinical Support for COVID-19 Study

Partners with Humanigen for FDA-approved Phase 3 lenzilumab study for COVID-19 patients

Contract Pharma Staff 05.08.20

Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Trials & Filings

Humanigen Initiates Phase III Lenzilumab Study in COVID-19

Catalent provides clinical supply support to Humanigen and its partners from its Philadelphia facility

Contract Pharma Staff 05.07.20

Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News

TEDOR Pharma, Rhode Island Hospital in Clinical Mfg. Pact

To provide cGMP contract manufacturing services to support a clinical trial exploring the safety and efficacy of Praziquantel in children under the age of four.

Contract Pharma Staff 05.05.20

Bio News | Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Scale-up/Technology Transfer

NJII Names BioCentriq as Cell & Gene Therapy Mfg. Center

Newark, NJ process development and clinical manufacturing facility for cell and gene therapies becomes first of its kind located on a U.S. university campus.

Videos